{"id":"https://openalex.org/W2593834656","doi":"https://doi.org/10.22159/ajpcr.2017.v10i3.16380","title":"A CLINICAL STUDY ON ADVERSE DRUG REACTIONS OF COMBINATION THERAPY OF DAPAGLIFLOZIN AND METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS","display_name":"A CLINICAL STUDY ON ADVERSE DRUG REACTIONS OF COMBINATION THERAPY OF DAPAGLIFLOZIN AND METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS","publication_year":2017,"publication_date":"2017-03-01","ids":{"openalex":"https://openalex.org/W2593834656","doi":"https://doi.org/10.22159/ajpcr.2017.v10i3.16380","mag":"2593834656"},"language":"en","primary_location":{"id":"doi:10.22159/ajpcr.2017.v10i3.16380","doi":"https://doi.org/10.22159/ajpcr.2017.v10i3.16380","is_oa":true,"landing_page_url":"https://doi.org/10.22159/ajpcr.2017.v10i3.16380","pdf_url":"https://innovareacademics.in/journals/index.php/ajpcr/article/download/16380/10134","source":{"id":"https://openalex.org/S2764968390","display_name":"Asian Journal of Pharmaceutical and Clinical Research","issn_l":"0974-2441","issn":["0974-2441","2455-3891"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-40"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asian Journal of Pharmaceutical and Clinical Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://innovareacademics.in/journals/index.php/ajpcr/article/download/16380/10134","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043197870","display_name":"Syed Safiullah Ghori","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Syed Safiullah Ghori","raw_affiliation_strings":["Anwarulaloom College of pharmacy\r\nMallepally,Hyderabad-500001"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anwarulaloom College of pharmacy\r\nMallepally,Hyderabad-500001","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"Amit Kapoor","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amit Kapoor","raw_affiliation_strings":["Department of Hospital and Clinical Pharmacy, Anwar-Ul-Uloom College of Pharmacy, New Mallepally, Hyderabad, Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hospital and Clinical Pharmacy, Anwar-Ul-Uloom College of Pharmacy, New Mallepally, Hyderabad, Telangana, India","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.02688375,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"10","issue":"3","first_page":"406","last_page":"406"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":1.0},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8320000171661377},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9850000143051147},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.890999972820282},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8809999823570251},{"id":"https://openalex.org/keywords/postprandial-blood-glucose","display_name":"postprandial blood glucose","score":0.8970000147819519},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.7459999918937683},{"id":"https://openalex.org/keywords/serum-insulin","display_name":"serum insulin","score":0.8360000252723694},{"id":"https://openalex.org/keywords/beta-cell-function","display_name":"beta-cell function","score":0.8709999918937683},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.8849999904632568}],"concepts":[{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.9103130102157593},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.9003063440322876},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8972620964050293},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.8636949062347412},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.707794189453125},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6902468204498291},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.6860741376876831},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6427861452102661},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4993631839752197},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4723212420940399},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4507066607475281},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.44895800948143005},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.44243323802948},{"id":"https://openalex.org/C2777538456","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated hemoglobin","level":4,"score":0.43785426020622253},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.39476248621940613},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3591911792755127}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.22159/ajpcr.2017.v10i3.16380","doi":"https://doi.org/10.22159/ajpcr.2017.v10i3.16380","is_oa":true,"landing_page_url":"https://doi.org/10.22159/ajpcr.2017.v10i3.16380","pdf_url":"https://innovareacademics.in/journals/index.php/ajpcr/article/download/16380/10134","source":{"id":"https://openalex.org/S2764968390","display_name":"Asian Journal of Pharmaceutical and Clinical Research","issn_l":"0974-2441","issn":["0974-2441","2455-3891"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-40"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asian Journal of Pharmaceutical and Clinical Research","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.22159/ajpcr.2017.v10i3.16380","doi":"https://doi.org/10.22159/ajpcr.2017.v10i3.16380","is_oa":true,"landing_page_url":"https://doi.org/10.22159/ajpcr.2017.v10i3.16380","pdf_url":"https://innovareacademics.in/journals/index.php/ajpcr/article/download/16380/10134","source":{"id":"https://openalex.org/S2764968390","display_name":"Asian Journal of Pharmaceutical and Clinical Research","issn_l":"0974-2441","issn":["0974-2441","2455-3891"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-40"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asian Journal of Pharmaceutical and Clinical Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2593834656.pdf","grobid_xml":"https://content.openalex.org/works/W2593834656.grobid-xml"},"referenced_works_count":5,"referenced_works":["https://openalex.org/W1985882361","https://openalex.org/W2029749250","https://openalex.org/W2134293572","https://openalex.org/W2547163033","https://openalex.org/W2994334405"],"related_works":["https://openalex.org/W4403342332","https://openalex.org/W4312865223","https://openalex.org/W4394766808","https://openalex.org/W7218060902","https://openalex.org/W2189696564","https://openalex.org/W7171858552","https://openalex.org/W2356609792","https://openalex.org/W6967495785","https://openalex.org/W4210645819","https://openalex.org/W7129092447"],"abstract_inverted_index":{"ABSTRACTObjective:":[0],"This":[1],"study":[2,33,197],"aimed":[3],"at":[4,111],"determination":[5],"of":[6,10,13,20,26,41,57,60,98,114,121,174,202],"safety":[7],"and":[8,15,38,71,78,91,186,189,211,234],"efficacy":[9,63],"combination":[11,140,184,201],"therapy":[12,141,185],"dapagliflozin":[14,139,183],"metformin":[16,181,187],"in":[17,31,50,119,127,135,165,207],"the":[18,32,42,48,96,107,115,129,196,200,203,222],"treatment":[19,131,175],"Type2":[21],"diabetes":[22],"mellitus.Methods:":[23],"A":[24],"total":[25],"50":[27],"patients":[28,136,223],"were":[29,93,125,142,213,219],"enrolled":[30],"depending":[34],"on":[35],"demographic":[36],"parameters":[37,64],"clinical":[39,108],"data":[40],"patients.":[43,103],"The":[44,133,193],"primaryefficacy":[45],"criterion":[46],"was":[47,147,205],"change":[49],"glycated":[51],"hemoglobin":[52],"(HbA1c)":[53],"after":[54,67,81,86],"a":[55,82],"minimum":[56],"12":[58,68,87],"weeks":[59],"treatment.":[61,89],"Secondary":[62],"wereHbA1c":[65],"value":[66],"weeks,":[69],"fasting":[70,166],"1":[72],"hrs":[73],"postprandial":[74,122,151,156],"glucose,":[75],"serum":[76,167],"insulin":[77,153,168],"triglyceride":[79],"levels,":[80],"standardized":[83],"meal,":[84],"all":[85,128],"weeksof":[88],"Safety":[90],"tolerability":[92],"evaluated":[94],"by":[95,102,221],"incidence":[97],"adverse":[99,216],"events":[100],"reported":[101,220],"Patient":[104],"visits":[105],"to":[106,172],"center":[109],"werescheduled":[110],"screening,":[112],"start":[113],"run-in":[116],"period.Results:":[117],"Reductions":[118],"levels":[120,159,210],"plasma":[123,152,157],"glucose":[124,158],"observed":[126,169],"active":[130],"groups.":[132],"reductions":[134],"receivingmetformin":[137],"plus":[138,182],"significantly":[143,179],"greater":[144],"(p<0.0001).":[145],"It":[146],"clear":[148],"that":[149,199],"lower":[150],"levelsdespite":[154],"higher":[155],"suggest":[160,198],"decreased":[161],"\u03b2-cell":[162],"function.":[163],"Changes":[164],"from":[170,195],"baseline":[171],"theend":[173],"did":[176],"not":[177],"differ":[178],"between":[180],"monotherapy":[188],"showed":[190],"noconsistent":[191],"trend.Conclusion:":[192],"results":[194],"drugs":[204],"effective":[206],"controlling":[208],"glycemic":[209],"also":[212],"safe.":[214],"Noserious":[215],"drug":[217],"reactions":[218],"when":[224],"used":[225],"daily":[226],"once":[227],"for":[228],"6":[229],"months.Keywords:":[230],"Dapagliflozin,":[231],"Metformin,":[232],"Postprandial":[233],"glycemic.":[235]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-03-16T00:00:00"}